Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 14/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | MPL | P40238 | 3/20 | 0.49 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.44 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.43 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.43 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.43 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1805256 | 0.85 | MCL1 (0.71) | MCL1CYP2C9HSD17B10BCL2L1 | |
| SCHEMBL1805693 | 0.85 | CYP2C9 (0.43) | MCL1CYP2C9HSD17B10CYP2D6MPL | |
| SCHEMBL4368303 | 0.83 | MCL1 (0.51) | MCL1CYP2C9HSD17B10CYP2D6MPL | |
| SCHEMBL1808593 | 0.83 | MCL1 (0.73) | MCL1CYP2C9HSD17B10CYP2D6MPL | |
| SCHEMBL7207391 | 0.81 | SENP2 (0.56) | MCL1CYP2C9HSD17B10CYP2D6MPL | |
| SCHEMBL1805677 | 0.81 | TTR (0.50) | MCL1CYP2C9HSD17B10CYP2D6MPL | |
| SCHEMBL7206515 | 0.81 | MCL1 (0.50) | MCL1CYP2C9HSD17B10CYP2D6MPL | |
| SCHEMBL9845555 | 0.81 | MCL1 (0.50) | MCL1CYP2C9HSD17B10CYP2D6MPL | |
| SCHEMBL29472291 | 0.77 | CYP2D6 (0.50) | MCL1CYP2C9HSD17B10CYP2D6MPL | |
| SCHEMBL7190686 | 0.77 | CYP2D6 (0.50) | MCL1CYP2C9HSD17B10CYP2D6MPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404036-B2 | Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | IK, RB1, COL1A1 | MCL1 3071/4885CYP2C9 692/4885HSD17B10 2848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.